Biodesix (BDSX) Depreciation & Amortization (CF) (2019 - 2026)

Biodesix (BDSX) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $1.4 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 3.06% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 million (down 2.92% YoY) and the FY2025 annual result came in at $5.7 million, down 1.78% from the prior year.
• Depreciation & Amortization (CF) advanced to $1.4 million in Q1 2026, from $1.4 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.5 million in Q3 2024 to a low of $782000.0 in Q3 2023.
• A 5-year average of $1.2 million and a median of $1.4 million in 2025 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) retreated 13.55% — and 2024, when it surged 90.92%.
• Tracing BDSX's Depreciation & Amortization (CF) over 5 years: stood at $898000.0 in 2022, then rose by 8.8% to $977000.0 in 2023, then jumped by 48.31% to $1.4 million in 2024, then dropped by 4.28% to $1.4 million in 2025, then gained by 0.65% to $1.4 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $1.4 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.